OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

The Medical News ·
Health & Medicine United Kingdom

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of four newly available IVDR-certified CytoCell® fluorescence in situ hybridization (FISH) probes as part of its ongoing commitment to transition the CytoCell FISH portfolio from CE marking under the IVD Directive (IVDD) to the IVD Regulation (IVDR) ahead of the Class C deadline of 31 December…

Read original article on The Medical News →

Related news